Skip to main content
Premium Trial:

Request an Annual Quote

Millennium Aligns With Two Biotech Institutions

Premium

CAMBRIDGE, Mass.--Millennium Pharmaceuticals has launched a strategic initiative to build a network of clinical research alliances to enhance its drug discovery, development, and predictive medicine efforts, the company said. Research collaborations of three years each with the University of Texas M.D. Anderson Cancer Center and the University of Pittsburgh are expected to provide Millen nium with clinical expertise and access to clinical samples and tissue collections. Millen nium said the alliances will broaden its capabilities in the large scale identification and characterization of novel gene targets and markers important for the prognosis, diagnosis, and treatment of major human diseases.

Millennium's collaboration with M.D. Anderson focuses on the collection of information derived from clinical samples and tissue collections in the field of oncology.

The collaboration with the University of Pittsburgh Medical Center Health System aims to develop a comprehensive tissue bank and informatics resources to further the understanding of human disease processes and facilitate the identification of molecular targets, Millennium said.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.